Editorial comment--Utility of abciximab during carotid stenting when distal protection is contraindicated.
Elad I
EI
Levy
L Nelson
LN
Hopkins
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects; D002545:Brain Ischemia / Q000209:etiology / Q000517:prevention & control; D002340:Carotid Artery Diseases / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D015607:Stents / Q000009:adverse effects; D013927:Thrombosis / Q000517:prevention & control; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab